Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
56,638,847
-
Shares change
-
+1,976,064
-
Total reported value, excl. options
-
$1,582,549,935
-
Value change
-
+$86,587,271
-
Put/Call ratio
-
68%
-
Number of buys
-
78
-
Number of sells
-
-85
-
Price
-
$28.00
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q3 2025
208 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q3 2025.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,638,847 shares
of 172,779,139 outstanding shares and own 33% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5,689,187 shares), FMR LLC (5,250,368 shares), Avoro Capital Advisors LLC (5,155,555 shares), JANUS HENDERSON GROUP PLC (4,448,826 shares), Deep Track Capital, LP (4,215,811 shares), BVF INC/IL (3,203,917 shares), BAKER BROS. ADVISORS LP (1,556,109 shares), Casdin Capital, LLC (1,555,000 shares), RA CAPITAL MANAGEMENT, L.P. (1,517,418 shares), and MILLENNIUM MANAGEMENT LLC (1,274,551 shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.